1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015" provides data on the Nonseminomatous Testicular Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonseminomatous Testicular Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonseminomatous Testicular Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Nonseminomatous Testicular Cancer 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Nonseminomatous Testicular Cancer 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Drugs 24
Clinical Trial Overview of Top Institutes / Government 25
Memorial Sloan Kettering Cancer Center 25
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 25
National Cancer Institute 26
Clinical Trial Overview of National Cancer Institute 26
Abramson Cancer Center 27
Clinical Trial Overview of Abramson Cancer Center 27
Cambridge University Hospitals NHS Foundation Trust 28
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 28
City of Hope 29
Clinical Trial Overview of City of Hope 29
Deutsche Krebshilfe e.V. 30
Clinical Trial Overview of Deutsche Krebshilfe e.V. 30
European Organization for Research and Treatment of Cancer 31
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 31
Indiana University School of Medicine 32
Clinical Trial Overview of Indiana University School of Medicine 32
Institute of Cancer Research 33
Clinical Trial Overview of Institute of Cancer Research 33
Masonic Cancer Center 34
Clinical Trial Overview of Masonic Cancer Center 34
Five Key Clinical Profiles 35
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 66

List of Tables
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 6
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 16
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 17
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Nonseminomatous Testicular Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Nonseminomatous Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 25
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 26
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2015* 27
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2015* 28
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope, 2015* 29
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsche Krebshilfe e.V., 2015* 30
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 31
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015* 32
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Cancer Research, 2015* 33
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2015* 34

List of Figures
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Nonseminomatous Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Nonseminomatous Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 16
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18
Nonseminomatous Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Nonseminomatous Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Nonseminomatous Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24
GlobalData Methodology 64

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.